UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1008-1008

2016

Volltextzugriff (PDF)

SUBSTANTIAL REDUCTION OF HEREDITARY ANGIOEDEMA ATTACK SYMPTOM BURDEN IN THE SEBETRALSTAT PHASE 3 KONFIDENT TRIAL

Annals of allergy, asthma, & immunology, 2024-11, Vol.133 (6), p.S28

2024

Volltextzugriff (PDF)

CORRELATION OF TIME TO TREATMENT WITH ATTACK DURATION IN THE SEBETRALSTAT PHASE 3 KONFIDENT TRIAL

Annals of allergy, asthma, & immunology, 2024-11, Vol.133 (6), p.S29

2024

Volltextzugriff (PDF)

INDIRECT TREATMENT COMPARISON OF ORAL SEBETRALSTAT AND INTRAVENOUS RHC1-INH AS ON-DEMAND TREATMENTS FOR HEREDITARY ANGIOEDEMA

Annals of allergy, asthma, & immunology, 2024-11, Vol.133 (6), p.S28-S29

2024

Volltextzugriff (PDF)

P052 RELATIONSHIP BETWEEN PGI-C SCALE AND OTHER PROS IN KVD900 TRIAL IN HAE

Annals of allergy, asthma, & immunology, 2021-11, Vol.127 (5), p.S29

2021

Volltextzugriff (PDF)

DIAGNOSING HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH) – A REAL WORLD ACARE SURVEY

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S34-S34

2023

Volltextzugriff (PDF)

TREATMENT OF HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH) – A REAL-WORLD ACARE SURVEY

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S30-S30

2023

Volltextzugriff (PDF)

REFINING PREVALENCE ESTIMATES OF HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH)

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S34-S34

2023

Volltextzugriff (PDF)

ON-DEMAND TREATMENT OF LARYNGEAL HEREDITARY ANGIOEDEMA ATTACKS WITH SEBETRALSTAT: POOLED ANALYSIS FROM KONFIDENT AND KONFIDENT-S

Annals of allergy, asthma, & immunology, 2024-11, Vol.133 (6), p.S33-S33

2024

Volltextzugriff (PDF)

REAL-WORLD TREATMENT BURDEN ASSOCIATED WITH PARENTERAL ON-DEMAND THERAPIES FOR HEREDITARY ANGIOEDEMA

Annals of allergy, asthma, & immunology, 2022-11, Vol.129 (5), p.S15-S16

2022

Volltextzugriff (PDF)

P52 Burden of the Untreated Attacks and Its Impact on Social, Mental and Physical Health

Value in health, 2024-06, Vol.27 (6), p.S12-S12

2024

Volltextzugriff (PDF)

P24 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

Value in health, 2024-06, Vol.27 (6), p.S6-S6

2024

Volltextzugriff (PDF)

EE5 Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database

Value in health, 2024-06, Vol.27 (6), p.S57-S58

2024

Volltextzugriff (PDF)

The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics

American journal of nephrology, 2009-01, Vol.30 (3), p.280-286

2009

Volltextzugriff (PDF)

A022 ON-DEMAND ORAL TREATMENT WITH KVD900 FOR HAE ATTACKS ACHIEVES RAPID EXPOSURE AND IMPROVES PATIENT OUTCOMES

Annals of allergy, asthma, & immunology, 2021-11, Vol.127 (5), p.S4-S5

2021

Volltextzugriff (PDF)

PCR267 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

Value in health, 2024-06, Vol.27 (6), p.S346-S346

2024

Volltextzugriff (PDF)

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks

The New England journal of medicine, 2024-07, Vol.391 (1), p.32-43

2024

Volltextzugriff (PDF)

Correlates of Anemia in American Blacks and Whites : The REGARDS Renal Ancillary Study

American journal of epidemiology, 2009-02, Vol.169 (3), p.355-364

2009

Volltextzugriff (PDF)

Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study

Nephrology, dialysis, transplantation, 2012-05, Vol.27 (5), p.1942-1949

2012

Volltextzugriff (PDF)

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

Nephrology, dialysis, transplantation, 2013-11, Vol.28 (11), p.2841-2850

2013

Volltextzugriff (PDF)

Das Biosimilar Epoetin-zeta bei einer Sicherheitskohorte von Patienten mit renaler Anämie: Die PASCO-I-Studie

Nieren- und Hockdruckkrankheiten, 2016-05, Vol.45 (5), p.183-193

2016

Volltextzugriff (PDF)

Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: Baseline results

Kidney international, 2005-10, Vol.68 (4), p.1427-1431

2005

Volltextzugriff (PDF)

Darbepoetin alfa Administered Every Other Week Maintains Hemoglobin Levels over 52 Weeks in Patients with Chronic Kidney Disease Converting from Once-Weekly Recombinant Human Erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)

American journal of nephrology, 2006-01, Vol.26 (2), p.149-156

2006

Volltextzugriff (PDF)

HUS and diabetic nephropathy

Nephrology, dialysis, transplantation, 2012-05, Vol.27 (suppl 2), p.ii11-ii13

2012

Volltextzugriff (PDF)

PUK10 IMPROVED RESOURCE UTILIZATION OUTCOMES ASSOCIATED WITH PREDIALYSIS USE OF PARICALCITOL FOR SECONDARY HYPERPARATHYROIDISM (SHPT)

Value in health, 2010, Vol.13 (3), p.A77-A78

2010

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries

SUBSTANTIAL REDUCTION OF HEREDITARY ANGIOEDEMA ATTACK SYMPTOM BURDEN IN THE SEBETRALSTAT PHASE 3 KONFIDENT TRIAL

CORRELATION OF TIME TO TREATMENT WITH ATTACK DURATION IN THE SEBETRALSTAT PHASE 3 KONFIDENT TRIAL

INDIRECT TREATMENT COMPARISON OF ORAL SEBETRALSTAT AND INTRAVENOUS RHC1-INH AS ON-DEMAND TREATMENTS FOR HEREDITARY ANGIOEDEMA

P052 RELATIONSHIP BETWEEN PGI-C SCALE AND OTHER PROS IN KVD900 TRIAL IN HAE

DIAGNOSING HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH) – A REAL WORLD ACARE SURVEY

TREATMENT OF HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH) – A REAL-WORLD ACARE SURVEY

REFINING PREVALENCE ESTIMATES OF HEREDITARY ANGIOEDEMA (HAE) WITH NORMAL C1-INH (HAE-NC1-INH)

ON-DEMAND TREATMENT OF LARYNGEAL HEREDITARY ANGIOEDEMA ATTACKS WITH SEBETRALSTAT: POOLED ANALYSIS FROM KONFIDENT AND KONFIDENT-S

REAL-WORLD TREATMENT BURDEN ASSOCIATED WITH PARENTERAL ON-DEMAND THERAPIES FOR HEREDITARY ANGIOEDEMA

P52 Burden of the Untreated Attacks and Its Impact on Social, Mental and Physical Health

P24 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

EE5 Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database

The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics

A022 ON-DEMAND ORAL TREATMENT WITH KVD900 FOR HAE ATTACKS ACHIEVES RAPID EXPOSURE AND IMPROVES PATIENT OUTCOMES

PCR267 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Quality of Life

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks

Correlates of Anemia in American Blacks and Whites : The REGARDS Renal Ancillary Study

Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study

Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial

Das Biosimilar Epoetin-zeta bei einer Sicherheitskohorte von Patienten mit renaler Anämie: Die PASCO-I-Studie

Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: Baseline results

Darbepoetin alfa Administered Every Other Week Maintains Hemoglobin Levels over 52 Weeks in Patients with Chronic Kidney Disease Converting from Once-Weekly Recombinant Human Erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)

HUS and diabetic nephropathy

PUK10 IMPROVED RESOURCE UTILIZATION OUTCOMES ASSOCIATED WITH PREDIALYSIS USE OF PARICALCITOL FOR SECONDARY HYPERPARATHYROIDISM (SHPT)

Suchergebnisse filtern